Wednesday February 26, 2020 0 comments
ENGLEWOOD -- Zynex, Inc. (NASDAQ: ZYXI) today announced the U.S. Food and Drug Administration granted 510(k) clearance for sale in the U.S. of the company’s CM-1500 Blood Volume Monitor.
Zynex is a medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics.
"I am very excited to finally have obtained FDA clearance to sell our non-invasive Blood Volume Monitor in the U.S.,” said Thomas Sandgaard, Zynex CEO.
“The device is fully developed, has performed well in multiple clinical trials and can guide medical professionals in hospitals and surgical centers towards better fluid management during surgery and in recovery settings.
“Fluid management during and after surgery is one of the largest un-met needs in hospitals today."
Founded in 1996, Zynex markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation.